News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
211,592 Results
Type
Article (7163)
Company Profile (38)
Press Release (204391)
Multimedia
Podcasts (24)
Webinars (5)
Section
Business (55518)
Career Advice (173)
Deals (10642)
Drug Delivery (45)
Drug Development (12390)
Employer Resources (35)
FDA (5794)
Job Trends (5352)
News (86922)
Policy (8651)
Tag
Academia (704)
Accelerated approval (1)
Adcomms (1)
Allergies (31)
Alliances (15269)
ALS (14)
Alzheimer's disease (332)
Antibody-drug conjugate (ADC) (25)
Approvals (5859)
Artificial intelligence (158)
Autoimmune disease (5)
Automation (5)
Bankruptcy (67)
Best Places to Work (4869)
BIOSECURE Act (4)
Biosimilars (55)
Biotechnology (18)
Bladder cancer (28)
Brain cancer (4)
Breast cancer (101)
Cancer (592)
Cardiovascular disease (68)
Career advice (166)
Career pathing (2)
CAR-T (21)
Cell therapy (86)
Cervical cancer (7)
Clinical research (10625)
Collaboration (298)
Compensation (25)
Complete response letters (2)
COVID-19 (734)
CRISPR (11)
C-suite (109)
Cystic fibrosis (19)
Data (693)
Decentralized trials (1)
Denatured (10)
Depression (14)
Diabetes (92)
Diagnostics (3225)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (36)
Drug pricing (47)
Drug shortages (6)
Duchenne muscular dystrophy (34)
Earnings (18052)
Editorial (16)
Employer branding (1)
Employer resources (31)
Events (48322)
Executive appointments (310)
FDA (6322)
Frontotemporal dementia (4)
Funding (276)
Gene editing (24)
Generative AI (17)
Gene therapy (73)
GLP-1 (181)
Government (1357)
Grass and pollen (2)
Guidances (52)
Healthcare (8623)
Huntington's disease (2)
IgA nephropathy (14)
Immunology and inflammation (19)
Indications (13)
Infectious disease (788)
Inflammatory bowel disease (42)
Inflation Reduction Act (5)
Influenza (16)
Intellectual property (20)
Interviews (15)
IPO (4305)
IRA (16)
Job creations (712)
Job search strategy (154)
Kidney cancer (1)
Labor market (4)
Layoffs (76)
Legal (1651)
Liver cancer (16)
Lung cancer (80)
Lymphoma (40)
Machine learning (3)
Management (14)
Manufacturing (82)
MASH (24)
Medical device (6150)
Medtech (6150)
Mergers & acquisitions (6606)
Metabolic disorders (243)
Multiple sclerosis (37)
NASH (5)
Neurodegenerative disease (17)
Neuropsychiatric disorders (8)
Neuroscience (466)
NextGen: Class of 2025 (2902)
Non-profit (1544)
Now hiring (3)
Obesity (130)
Opinion (66)
Ovarian cancer (16)
Pain (20)
Pancreatic cancer (12)
Parkinson's disease (22)
Partnered (7)
Patents (39)
Patient recruitment (36)
Peanut (19)
People (18618)
Pharmaceutical (12)
Pharmacy benefit managers (9)
Phase I (2246)
Phase II (3736)
Phase III (5068)
Pipeline (432)
Policy (47)
Postmarket research (735)
Preclinical (728)
Press Release (10)
Prostate cancer (37)
Psychedelics (5)
Radiopharmaceuticals (75)
Rare diseases (110)
Real estate (1405)
Recruiting (11)
Regulatory (6359)
Reports (16)
Research institute (627)
Resumes & cover letters (13)
Rett syndrome (3)
RNA editing (1)
RSV (17)
Schizophrenia (20)
Series A (43)
Series B (41)
Service/supplier (3)
Sickle cell disease (25)
Special edition (6)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1230)
Stomach cancer (2)
Supply chain (24)
Tariffs (14)
The Weekly (14)
Vaccines (163)
Venture capitalists (17)
Weight loss (65)
Women's health (21)
Worklife (2)
Date
Today (98)
Last 7 days (286)
Last 30 days (909)
Last 365 days (11505)
2025 (4305)
2024 (11923)
2023 (13065)
2022 (20209)
2021 (21553)
2020 (20909)
2019 (17772)
2018 (13128)
2017 (8987)
2016 (9589)
2015 (11009)
2014 (8131)
2013 (6711)
2012 (6999)
2011 (6966)
2010 (5591)
Location
Africa (230)
Alabama (14)
Alaska (1)
Arizona (71)
Arkansas (6)
Asia (11000)
Australia (1469)
California (1842)
Canada (644)
China (166)
Colorado (124)
Connecticut (83)
Delaware (54)
Europe (26645)
Florida (325)
Georgia (94)
Hawaii (1)
Idaho (18)
Illinois (232)
India (18)
Indiana (141)
Iowa (1)
Japan (82)
Kansas (23)
Kentucky (14)
Louisiana (8)
Maine (26)
Maryland (245)
Massachusetts (1470)
Michigan (94)
Minnesota (136)
Mississippi (2)
Missouri (55)
Montana (5)
Nebraska (13)
Nevada (20)
New Hampshire (25)
New Jersey (723)
New Mexico (7)
New York (632)
North Carolina (415)
North Dakota (1)
Northern California (824)
Ohio (68)
Oklahoma (6)
Oregon (11)
Pennsylvania (543)
Puerto Rico (3)
Rhode Island (8)
South America (310)
South Carolina (11)
Southern California (686)
Tennessee (72)
Texas (263)
United States (8013)
Utah (106)
Virginia (49)
Washington D.C. (25)
Washington State (150)
West Virginia (3)
Wisconsin (26)
211,592 Results for "genequantum healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates
Nona Biosciences announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-generation bioconjugates.
November 13, 2023
·
3 min read
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development
Thousand Oaks Biologics Inc. and GeneQuantum Healthcare Co., Ltd. are pleased to announce that they have formed a strategic partnership focusing on the CMC development of ADC products with a core conjugation technology for more stable drug candidates.
May 22, 2023
·
3 min read
Business
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development
GeneQuantum and InxMed, a clinical-stage biotechnology company dedicates on developing innovative therapies targeting drug resistance for hard-to-treat solid tumors, signed a collaboration agreement.
July 17, 2023
·
5 min read
Policy
GeneQuantum Healthcare’s Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia
GeneQuantum Healthcare Co., Ltd. announced that two of the company’s bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum’s pipelines in the clinical stage.
May 15, 2022
·
2 min read
Business
GeneQuantum announces a key leadership appointment
GeneQuantum Healthcare announced a key appointment to further strengthen GeneQuantum management team.
August 15, 2021
·
2 min read
Business
GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate
GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate.
April 18, 2022
·
3 min read
Business
GeneQuantum announces two key leadership appointments
GeneQuantum Healthcare announced the appointment of Dr. Li Wan as the Senior Vice President and Head of Global Regulatory Affairs, Dr. Weimeng Zhao as Vice President of Quality Research and Quality, to further strengthen the GeneQuantum management team.
September 15, 2021
·
3 min read
IN PARTNERSHIP WITH DIA
Beyond Neutrality: How Nonprofit Organizations Drive Healthcare Innovation and Collaboration
Health-focused nonprofits like the Drug Information Association (DIA) serve as crucial bridge-builders in the healthcare ecosystem during a time of uncertainty.
April 7, 2025
·
7 min read
·
BioSpace Insights
Business
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates
GeneQuantum Healthcare Co.,Ltd. and BrighGene Biomedical Co.,Ltd. signed a co-development agreement for antibody immune agonist conjugate, GQ1007.
September 5, 2021
·
4 min read
Press Releases
Schrödinger to Present at BofA Securities 2025 Healthcare Conference
May 5, 2025
·
1 min read
1 of 21,160
Next
